Testing effectiveness (Phase 2)Ended earlyNCT00023881What this trial is testingBortezomib in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00410657What this trial is testingAlemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center 53
Large-scale testing (Phase 3)Study completedNCT00719563What this trial is testingAmerican Ginseng in Treating Patients With Fatigue Caused by CancerWho this might be right forChronic Myeloproliferative DisordersFatigueLeukemia+7 more Alliance for Clinical Trials in Oncology 364
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Not applicableLooking for participantsNCT07362225What this trial is testingMPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)Who this might be right forPolycythemia VeraET (Essential Thrombocythemia)Polycythemia Vera (PV)+52 more MPN Research Foundation 5,000
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT00081133What this trial is testingArsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT05367700What this trial is testingHS-10382 in Patients With Chronic Myeloid Leukemia.Who this might be right forCML, Chronic PhaseCML, Accelerated Phase Jiangsu Hansoh Pharmaceutical Co., Ltd. 108
Large-scale testing (Phase 3)Study completedNCT00045292What this trial is testingValacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00109993What this trial is testingCampath-1H + FK506 and Methylprednisolone for GVHDWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT00827099What this trial is testingUmbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+2 more Northside Hospital, Inc. 5
Not applicableEnded earlyNCT00957736What this trial is testingChronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forCancer Vanderbilt-Ingram Cancer Center 252
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Early research (Phase 1)Ended earlyNCT01426334What this trial is testingDasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib MesylateWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia+1 more National Cancer Institute (NCI) 4
Not applicableStudy completedNCT00060021What this trial is testingAcupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell TransplantationWho this might be right forCancer National Cancer Institute (NCI)
Not applicableStudy completedNCT00964821What this trial is testingFlu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 459
Testing effectiveness (Phase 2)Study completedNCT00806767What this trial is testingFludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Institut Paoli-Calmettes 82
Not applicableStudy completedNCT00376922What this trial is testingMusic in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+7 more Wake Forest University Health Sciences 65
Testing effectiveness (Phase 2)Study completedNCT00171223What this trial is testingAn Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-AlphaWho this might be right forLeukemia, Myelogenous, Chronic, BCR-ABL Positive Novartis Pharmaceuticals 532